Optical coherence tomography angiography (OCT-A) is relatively new technology, which allows the visualization of retinal and choroidal vascular layers with no need of dye injection.
1 Differently from fluorescein angiography, OCT-A permits the evaluation of retinal and choroidal vascular networks in a separate, noninvasive and three-dimensional fashion.
1 OCT-A relies on the principle that erythrocytes flowing in blood vessels are the only moving structure across co-registered sequential B-scans and, therefore, they can be used as a motion contrast to differentiate vessels from static tissues.
1 Based on this assumption, several algorithms have been developed by many instruments including complex optical microangiography (OMAG) for Zeiss devices (Angioplex and PLEX Elite 9000; Carl Zeiss Meditec, Inc., Dublin, CA, USA),
2,3 split spectrum amplitude decorrelation angiography algorithm (SSADA) for RTVue XR Avanti (Optovue Inc., Fremont, CA, USA),
4 OCT angiography ratio analyses (OCTARA) for DRI OCT Triton (Topcon, Tokyo, Japan),
5 and full-spectrum amplitude decorrelation algorithm (FSADA) for Heidelberg (Spectralis; HRA Heidelberg, Heidelberg, Germany).
6 All these machines provide en face angiogram images, which can be postprocessed in order to obtain quantitative parameters, such as foveal avascular zone (FAZ) area and vessel density. Many studies have reported that these parameters have high intra- and interoperator reproducibility both in eyes with and without retinal diseases, for the same scan type and for the same machine.
7–13 In a study by Dong and coworkers,
14 a good agreement between 3 × 3- and 6 × 6-mm angiocubes was found for choriocapillary vessel density and for FAZ area at all retina vasculatures; conversely, reliability for retinal vessel density was weak. However, scan interchangeability has been only tested for small angiocubes and it remains uncertain for wider size scans (e.g., 12 × 12 mm). One of the advantages of OCT-A compared with fluorescein angiography is the possibility to distinguish between superficial and deep plexuses; however, the effect of different scan sizes on interchangeability and interoperator reliability for each plexus is still unknown. In addition, interchangeability of 3 × 3- and 6 × 6-mm angiocubes has been demonstrated only for one spectral-domain (SD)-OCT-A device (Optovue) using an automatic method and only in healthy Chinese subjects.
14 Therefore, it remains unclear whether other instruments or manual measurements may yield different results, particularly when applied to individuals with retinal disorders.